Upstream Bio, Inc. aksje
UPB
After-hours$7.25-0.83 (-10.27%)
Post-Market:$7.34+0.09 (+1.24%)
Laster graf...
Upstream Bio, Inc.
Market Cap
$394,544,928
Åpning7.96
Høy7.96
Lav7.18
Volum533.35k
P/EN/A
Markedsverdi394.54M
52-ukers høy33.68
52-ukers lav7.18
Gj.sn. volum705.76k
UtbytteN/A
BetaN/A
EPS-2.90
Om Upstream Bio, Inc. aksje
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Selskapsinformasjon
Børs: NasdaqGS (NMS)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
890 Winter Street
02451 Waltham, United States
02451 Waltham, United States
Telefon: + 781 208 2466
Nettside: https://upstreambio.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.50 - Stærk køb
Laveste kursmål
15.00
↑ 106.9%
Gjennomsnittlig kursmål
42.43
↑ 485.2%
Median kursmål
42.00
↑ 479.3%
Høyeste kursmål
75.00
↑ 934.5%